Le Lézard
Classified in: Health
Subjects: PDT, SBS

Vytanutra Takes NATURAL Joint Supplements to a Whole New Level


IRVINE, Calif., Jan. 18, 2022 /PRNewswire/ -- Vytanutra (https://www.vytanutra.com/) announced its official launch of their newest product, Joint Care. Joint care contains an exclusive blend of scientifically supported nutrients that enhance overall joint health. The ingredients include Vitamin C, Manganese, Glucosamine sulfate, Methylsulfonylmethane (MSM), and a Chinese herbal formulation that consists of Corydalis root (Yuan Hu Suo), large-leaved Gentiana root (Qin Jiao) and Turmeric root tuber (yu jin) plays a role in supporting healthy joint and flexibility.

New Formulation Based on Chinese Herbal Lore

Research shows that the use of traditional Chinese medicine herbs, Corydalis root (Yuan Hu Suo) and Gentiana Root (Qin Jiao), help lessen discomfort throughout the body, including the joints.

Corydalis has been used as a pain reliever in traditional Chinese medicine. Many practitioners of Traditional Chinese herbal medicine consider Corydalis to be the second most effective herb for pain. More specifically, the corydalis plant contains a substance that affects the dopamine activity in the brain and in doing so, can cause feelings of sedation. It also contains anti-inflammatory properties to stop the transfer of signals related to discomfort from reaching the brain.

Gentian Root has been used in traditional Chinese medicine throughout Europe for over 2,000 years. As a liver tonic and digestive aid, it also has a long history of use in Ayurveda and traditional Chinese Medicine (TCM). Known for its rich anti-inflammatory properties, it can help the body get over inflammatory conditions. Consuming gentian roots prevents the immune system from attacking the healthy cells.

Joint Care Supplement Benefits:

Why choose Vytanutra?

As a family-owned company, we ensure to offer the highest quality products at affordable prices. We help people honor their varying nutritional and holistic wellness needs. Vytanutra products are vegan, gluten free, toxic free, trusted quality, made with care, plant-based, made in USA, supported by research studies, and manufactured in GMP certified facility. Vytanutra products are engineered to enhance normal body wellness, providing benefits like overall immune, joint, and eye health support.

*Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. 

Media Contact:
John Guszak, Marketing Manager
Phone: 800-909-4372
Email: [email protected]

Related Links
www.vytanutra.com

SOURCE Vytanutra


These press releases may also interest you

at 05:12
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
RaySearch publishes Annual Report for 2023
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica publishes Annual Report 2023
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Interim report January-March 2024: Medicover
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

More news about Health...


News published on and distributed by: